Health care industry
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its popular weight loss injection Wegovy and diabetes treatment Ozempic, arguing that the medications are […]
Read More
Inside the fall of 23andMe
Once worth $6 billion, 23andMe has lost 98% of its value and is on the verge of being delisted from the Nasdaq after all of its independent board members resigned in September. So what happened? Founded in 2006, 23andMe set out to revolutionize the once very exclusive genetic testing business with a direct-to-consumer model. Thanks […]
Read More
Danaher returns a key business to growth, and we’re raising our stock rating back to buy
Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter. Danaher’s revenue for the three months ended Sept. 27 advanced 3% year over year on a reported basis, to $5.8 billion, outpacing the LSEG consensus estimate of $5.59 billion. On an organic basis, sales were […]
Read More
Walmart will start delivering prescriptions to customers’ doorsteps as CVS and Walgreens struggle
Walmart will start to deliver prescriptions to customers’ doorsteps. Customers can also get additional items dropped off along with medications, such as groceries. Courtesy of Walmart As CVS and Walgreens shutter hundreds of stores nationwide to shore up profits and investor sentiment, Walmart said Tuesday that it is offering a new option for customers: delivering […]
Read More
Lilly sues online vendors, medical spa over copycat weight-loss drugs
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets. The new lawsuits, which […]
Read More
GE HealthCare announces time-saving AI tool for doctors who treat cancer
GE Healthcare booth is seen ahead of the 2022 China International Fair for Trade in Services (CIFTIS) at China National Convention Center on August 28, 2022 in Beijing, China. Yi Haifei | China News Service | Getty Images GE HealthCare on Monday announced a new artificial intelligence application it said will save time for doctors […]
Read More
Apple’s AirPods Pro 2 will soon work as a hearing aid. Here’s what it’s like
Apple CEO Tim Cook delivers remarks before the start of an Apple event at the Apple headquarters in Cupertino, California, on Sept. 9, 2024. Justin Sullivan | Getty Images I tested the new hearing health features coming to Apple‘s AirPods Pro 2 headphones, and they saved me a long-overdue trip to the audiologist. Apple unveiled […]
Read More
Nvidia, Google, Microsoft and more head to Las Vegas to tout health-care AI tools
Visitors check out Nvidia’s AI technology at the 2024 Apsara Conference in Hangzhou, China, on September 19, 2024. Costfoto | Nurphoto | Getty Images Nvidia, Google, Microsoft and dozens of other tech companies are descending on Las Vegas next week to showcase artificial intelligence tools they say will save doctors and nurses valuable time. Sunday […]
Read More
Drug costs, abortion, Obamacare: How Trump and Harris could change U.S. health care
President Donald Trump talks to the press outside the White House, July 19, 2019, left, and Democratic presidential nominee and U.S. Vice President Kamala Harris speaks to mark the one-year anniversary of the Oct. 7 Hamas attacks on Israel, at the vice president’s residence at the U.S. Naval Observatory in Washington, Oct. 7, 2024. Getty […]
Read More
These dividend-paying stocks could be in the ‘early innings’ of a rally
It’s time to step back into health-care stocks, according to Wolfe Research. The sector was one of the worst performing over the past month, pulling back over 4% from September to October, technical analyst Rob Ginsberg wrote in a note on Tuesday. “As evidenced by XLV [Health Care Select Sector SPDR Fund], price is back […]
Read More